Morales et al. also observed a higher percentage of circulating IL10+CD4+ T cells in EBV-positive Hodgkin Lymphoma (HL) patients compared to HL patients without EBV and healthy controls [59]. This evidence concerns the gene CD4 and Hodgkins lymphoma.